LGND
Ligand Pharmaceuticals Incorporated · Healthcare · Biotechnology
Données momentum (gérants comparables) : étendue des détenteurs 0.0% · flux d'actions +1.2% · nouvelles positions nettes 0.0% — formule
Toutes les données de détention : gérants 13F suivis uniquement, positions en actions ordinaires, période de référence Q2 2025
| Trimestre | Détenteurs | Δ | Actions | Valeur déclarée | Nouveau | Sorties |
|---|---|---|---|---|---|---|
| Q2 2026 | 110 | +7 | 14.86M | $4.69B | +13 | −6 |
| Q1 2026 | 106 | -5 | 14.62M | $2.92B | +4 | −9 |
| Q4 2025 | 110 | 0 | 15.70M | $2.97B | +1 | −1 |
| Q3 2025 | 17 | +2 | 7.48M | $1.32B | +3 | −2 |
| Q2 2025 | 13 | 0 | 6.47M | $735.39M | +3 | −3 |
| Q1 2025 | 10 | +3 | 1.36M | $143.17M | +3 | — |
| Q4 2024 | 7 | -2 | 1.36M | $145.21M | — | −2 |
| Q3 2024 | 8 | -2 | 597.13K | $59.78M | — | −2 |
| Q2 2024 | 10 | — | 659.66K | $55.58M | — | — |
| # | Gérant | Actions | Δ actions | Valeur | Leur poids | Détenu | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passif) | 2.91M | — | $331.23M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passif) | 2.09M | — | $237.52M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passif) | 2.09M | — | $237.52M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (passif) | 2.09M | — | $237.52M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (passif) | 2.09M | — | $237.52M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passif) | 2.09M | — | $237.52M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passif) | 749.75K | +3.1% | $85.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Geode Capital Management ✦ (passif) | 488.78K | +5.2% | $55.57M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Geode Capital Management ✦ (passif) | 488.78K | +5.2% | $55.57M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 106.07K | -1.3% | $12.06M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 41.91K | Nouveau | $4.76M | 0.0% | New | 1 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 41.91K | Nouveau | $4.76M | 0.0% | New | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 26.22K | — | $2.98M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 26.22K | — | $2.98M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 17.97K | +10.2% | $2.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 17.97K | +10.2% | $2.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Norges Bank ✦ (passif) | 14.07K | -39.1% | $1.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 7.37K | -2.5% | $837,820 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 7.37K | -2.5% | $837,820 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 7.37K | -2.5% | $837,820 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 7.37K | -2.5% | $837,820 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | D. E. Shaw & Co. ✦ | 7.15K | Nouveau | $812,926 | 0.0% | New | 1 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 3.36K | +0.7% | $381,737 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 3.36K | +0.7% | $381,737 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 3.36K | +0.7% | $381,737 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Tweedy, Browne ✦ | 3.14K | Nouveau | $356,955 | 0.0% | New | 1 | SEC ↗ |
« Leur pondération » = la part de la position dans la valeur des actions 13F déclarées de ce gérant — la mesure de conviction. ✦ = gérant sélectionné.
Nouveaux acheteurs
| Citadel Advisors | $4.76M | 0.0% |
| Citadel Advisors | $4.76M | 0.0% |
| D. E. Shaw & Co. | $812,926 | 0.0% |
| Tweedy, Browne | $356,955 | 0.0% |
Sorti(e)
| Gotham Asset Management | $726,728 | était 0.0% |
| Two Sigma Investments | $294,392 | était 0.0% |
| Millennium Management | $270,946 | était 0.0% |
Contexte marché global: parmi TOUS les déposants 13F (données structurées SEC, Q1 2026): 353 détenteurs, 20.71M actions, $4.06B déclaré. Il s'agit d'une période différente et plus ancienne que les chiffres de l'univers suivi ci-dessus ; les deux ne sont jamais mélangés.
Ce que les détenteurs suivis de ce titre détiennent le plus souvent par ailleurs — nombre de détentions partagées, sans relation fondamentale sous-jacente.
Achats sur le marché libre (P)
Aucun achat d'initié sur le marché libre dans notre fenêtre de couverture.
Ventes sur le marché libre (S)
Officer · 31.64K act. · $9.24M
Director · 7.14K act. · $2.09M
Les attributions, exercices et retenues fiscales ne sont jamais comptabilisés comme des achats ou des ventes ici. Méthodologie